Article info
PDFResearch ethics
Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
- Correspondence to: Edwin J Wagena Pulmonary Rehabilitation Centre Hornerheide, PO Box 4080, 6080 AB Haelen, The Netherlands; edwinwagenaproteion.nl
Citation
Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?
Publication history
- Accepted February 17, 2004
- First published April 29, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey
- Science journal editors’ views on publication ethics: results of an international survey
- Ghosts in the machine
- Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature
- The White Bull effect: abusive coauthorship and publication parasitism
- Authorship ignorance: views of researchers in French clinical settings
- Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations
- Sixth version of the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”: lots of ethics, some new recommendations for manuscript preparation
- Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
- Authorship policies of scientific journals